Our findings may be relevant for the therapy of IgG-mediated autoimmune diseases such as PV, but may also be of importance for further autoimmune diseases that are based on FcRn-binding IgG, such as Graves disease, ITP and MG. This evidence concerns the gene FCGRT and autoimmune thrombocytopenic purpura.